Skip to main content

Published locations for Aducanumab and ARIA: Does the FDA’s prescribing label put patients at risk?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Aducanumab and ARIA: Does the FDA’s prescribing label put patients at risk?

User login

  • Reset your password
  • /content/aducanumab-and-aria-does-fdas-prescribing-label-put-patients-risk
  • /familypracticenews/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing
  • /neurologyreviews/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing-label
  • /psychiatry/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing-label-put
  • /neurology/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing-label-put
  • /familymedicine/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing-label
  • /clinicalpsychiatrynews/article/253133/alzheimers-cognition/aducanumab-and-aria-does-fdas-prescribing